Alexander J. Lazar, M.D., Ph.D.

Peer-Reviewed Articles

1. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. e-Pub 2024. PMID: 38351182.
2. Petralia F, Ma W, Yaron TM, Caruso FP, Tignor N, Wang JN, Charytonowicz D, Johnson JL, Huntsman EM, Marino GB, Calinawan A, Evangelista JE, Selvan ME, Chowdhury S, Rykunov D, Krek A, Song X, Turhan B, Christianson KE, Lewis DA, Deng EZ, Clarke DJB, Whiteaker JR, Kennedy JJ, Zhao L, Lazcano R, Batra H, Raso G, Parra ER, Soundararajan R, Tang X, Li Y, Yi X, Satpathy S, Wang Y, Wiznerowicz M, González-Robles TJ, Iavarone A, Gosline SJC, Reva B, Robles AI, Nesvizhskii AI, Mani DR, Gillette M, Klein RJ, Cieslik M, Zhang B, Paulovich AG, Sebra R, Gümüş ZH, Hostetter G, Fenyö D, Omenn GS, Cantley LC, Ma'ayan A, Lazar AJ, Ceccarelli M, Wang P, and Clinical Proteomic Tumor Analysis Consortium. Pan-cancer proteogenomics characterization of tumor immunity. Cell 4(9):101173, 2024. PMID: 38359819.
3. Cass SH, Tobin JWD, Seo YD, Gener-Ricos G, Keung EZ, Burton EM, Davies MA, McQuade JL, Lazar AJ, Mason R, Millward M, Sandhu S, Khoo C, Warburton L, Guerra V, Haydon A, Dearden H, Menzies AM, Carlino M, Smith JL, Mollee P, Burgess M, Mapp S, Keane C, Atkinson V, Parikh SA, Markovic SN, Ding W, Call TG, Hampel PJ, Long GV, Wargo JA, Ferrajoli A. Efficacy of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma in Patients with Concomitant Chronic Lymphocytic Leukemia. Ann Oncol 34(9):796-805, 2023. PMID: 37414216.
4. Liang WW, Lu RJ, Jayasinghe RG, Foltz SM, Porta-Pardo E, Geffen Y, Wendl MC, Lazcano R, Kolodziejczak I, Song Y, Govindan A, Demicco EG, Li X, Li Y, Sethuraman S, Payne SH, Fenyö D, Henry Rodriguez H, Wiznerowicz M, Shen H, Mani DR, Rodland KD, Lazar AJ, Robles AI, Ding L, Clinical Proteomic Tumor Analysis Consortium. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell 41(9):1567-1585, 2023. PMID: 37582362.
5. Geffen Y, Anand S, Akiyama Y, Yaron TM, Song Y, Johnson JL, Govindan A, Babur O, Li Y, Huntsman E, Wang LB, Birger C, Heiman DI, Zhang Q, Miller M, Maruvka JE, Haradhvala NJ, Calinawan A, Belkin S, Kerelsky A, Clauser KR, Krug K, Satpathy S, Payne SH, Mani DR, Gillette MA, Dhanasekaran SM, Thiagarajan M, Mesri M, Rodriquez H, Robles AI, Carr SA, Lazar AJ, Aguet F , Cantley LC, Ding L, Getz G, Clinical Proteomic Tumor Analysis Consortium. Pan-Cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186(18):3845-3967, 2023. PMID: 37582358.
6. Goyal Y, Busch GT, Pillai M, Li J, Boe RH, Grody EI, Chelvanambi M, Dardani IP, Emert B, Bodkin N, Braun J, Fingerman D, Kaur A, Jain N, Ravindran PT, Mellis IA, Kiani K, Alicea GM, Fane ME, Ahmed SS, Li H, Chen Y, Chai C, Kaster J, Witt RG, Lazcano R, Ingram DR, Johnson SB, Wani K, Dunagin MC, Lazar AJ, Weeraratna AT, Wargo JA, Herlyn M, Raj A.. Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature 620(7974):651-659, 2023. PMID: 37468627.
7. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis V, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL. ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas-A Systematic Review of the Literature. Ann Surg Oncol 30(2):970-971, 2023. PMID: 36323987.
8. Li Y, Lih TSM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, Wu Y, Lu RJH, Clark DJ, Kolodziejczak I, Hong R, Chen S, Zhao Y, Chugh S, Caravan W, Al Deen NN, Hosseini N, Newton CJ, Krug K, Xu Y, Cho KC, Hu Y, Zhang Y, Kumar-Sinha C, Ma W, Calinawan A, Wyczalkowski MA, Wendl MC, Wang Y, Guo S, Zhang C, Le A, Dagar A, Hopkins A, Cho H, da Veiga Leprevost F. Jing H, Teo CG, Liu W, Reimers MA, Pachynski R, Lazar AJ, Chinnaiyan AM, Van Tine BA, Zhang B, Rodland KD, Getz G, Mani DR, Wang P, Chen F, Hostetter G, Thiagarajan M, Linehan WM, Fenyo D, Jewll SD, Omenn GS, Mehra R, Wiznerowicz M, Robles AI, Mesri M, Hiltke T, An E, Rodriguez H, Chan DW, Ricketts CJ, Nesvizhskii AI, Zhang H, Ding L, Clinical Proteomic Tumor Analysis Consortium. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell 41(1):139-163, 2023. PMID: 36563681.
9. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave S, De Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi L, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint Jr A, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Andreas Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W. The 5th Edition of the World Health Organization Classification of Lymphoid Tumours. Leukemia 36(7):1720-1748, 2022. PMID: 35732829.
10. Andrews MC, Oba J, Wu CJ, Zhu H, Karpinets T, Creasy CA, Forget MA, Yu X, Song X, Mao X, Robertson AG, Romano G, Li P, Burton EM, Lu Y, Sloane RS, Wani KM, Rai K, Lazar AJ, Haydu LE, Bustos MA, Shen J, Chen Y, Morgan MB, Wargo JA, Kwong LN, Haymaker CL, Grimm EA, Hwu P, Hoon DSB, Zhang J, Gershenwald JE, Davies MA, Futreal PA, Bernatchez C, Woodman SE. Multi-modal molecular programs regulate melanoma cell state. Nat Commun 13(1):4000, 2022. PMID: 35810190.
11. Vellano CP, White MG, Andrews MC, Chelvanambi M, Witt MG, Daniele JR, Titus M, McQuade J, Conforti F, Burton EM, Lastrapes MJ, Ologun G, Cogdill AP, Morad G, Prieto P, Lazar AJ, Chu Y, Han G, Khan MAW, Helmink B, Davies MA, Amaria RN, Kovacs JJ, Woodman SE, Patel S, Hwu P, Peoples M, Lee JE, Cooper ZA, Zhu H, Gao G, Banerjee H, Lau M, Gershenwald JE, Lucci A, Keung EZ, Ross MI, Pala L, Pagan E, Lazcano RS, Liu Q, Borthwick M, Lau E, Yates MS, Westin SN, Wani K, Tetzlaff MT, Haydu L, Mahendra M, Ma XY, Logothetis C, Kulstad Z, Johnson S, Hudgens CW, Feng N, Federico L, Long G, P. Futreal PA, Arur S, Tawbi HA, Moran AE, Wang L, Heffernan T, Marszalek J, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 616(7915):797-803, 2022. e-Pub 2022. PMID: 35705814.
12. Zullow HJ, Sankar A, Ingram DR, D’Avino AR, Same Guerra DD, D'Avino AR, Collings CK, Lazcano R, Liang Y, Qi J, Lazar AJ, Kadoch C. The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Molec Cell 82(9):1737-1750, 2022. PMID: 35390276.
13. Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell 40(5):509-523.e6, 2022. PMID: 35537412.
14. Wu CC, Beird HC, Lamhamedi-Cherradi SE, Soeung M, Ingram D, Truong DD, Porter RW, Krishnan S, Little L, Gumbs C, Zhang J, Titus M, Genovese G, Ludwig JA, Lazar AJ, Hayes-Jordan A, Futreal PA. Multi-Site Desmoplastic Small Round Cell Tumors Are Genetically Related and Immune-Cold. NPJ Precis Oncol 6(1):21, 2022. PMID: 35379887.
15. Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, Tang Z, Bassett R, Manekia J, Barkoh BA, Dang H, Roy-Chowdhuri S. Utilization of Cytology Smears Improves Success Rates of RNA-based Next-Generation Sequencing Gene Fusion Assays for Clinically Relevant Predictive Biomarkers. Cancer Cytopathology 129(5):374-382, 2021. PMID: 33119213.
16. Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Fouad Abdelhakeem AA, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal PA, Song S, Ajani JA, Wang L. Single-Cell Dissection of Intratumoral Heterogeneity and Lineage Diversity in Metastatic Gastric Adenocarcinoma. Nat Med 27(1):141-151, 2021. PMID: 33398161.
17. Fischer GM, Carapeto FCL, Joon AY, Haydu LA, Chen H, Wang F, Van Arnam JS, McQuade JL, Wani K, Kirkwood J, Tetzlaff MT, Lazar AJ, Tawbi HA, Gershenwald JE, Scoyler R, Long GV, Davies MA. Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker. Cancer Med 9(22):9650-8661, 2020. PMID: 33016647.
18. Demetri GD, Antonescu CR, Bjerkehagen B, Bovée JVMG, Boye K, Chacón M, Tos APD, Desai J, Fletcher JA, Gelderblom H, George S, Gronchi A, Haas RL, Hindi N, Hohenberger P, Joensuu H, Jones RL, Judson I, Kang YK, Kawai A, Lazar AJ, Le Cesne A, Maestro R, Maki RG, Martín J, Patel S, Penault-Llorca F, Raut CP, Rutkowski P, Safwat A, Sbaragllia M, Schaefer IM, Shen L, Serrano C, Schöffski P, Stacchiotti S, Hall KS, Tap WD, Thomas DM, Trent J, Valverde C, van der Graaf WTA, von Mehren M, Wagner A, Wardelmann E, Naito Y, Zalcberg J, Blay JY. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network. Ann Oncol 31(11):1506-1517, 2020. PMID: 32891793.
19. Qin Y, Bollin K, de Macedo MP, Carapeto F, Kim KB, Roszik J, Wani KM, Reuben A, Reddy ST, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Lazar AJ, Hwu P, Patel SP. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer 8(2):e000960, 2020. PMID: 33203661.
20. Maitituoheti M, Keung EZ, Tang M, Yan L, Alam H, Han G, Singh AK, Raman AT, Terranova C, Sarkar S, Orouji E, Amin SB, Sharma S, Williams M, Samant NS, Dhamdhere M, Zheng N, Shah T, Shah A, Axelrad JB, Anvar NE, Lin YH, Jiang S, Chang EQ, Ingram DR, Wang WL, Lazar AJ, Lee MG, Muller F, Wang L, Ying H, Rai K. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant Melanoma. Cell Rep 33(3):108293, 2020. PMID: 34289358.
21. Amgad M, Stovgaard ES, Balslev E, Thagaard J, Chen W, Dudgeon S, Sharma A, Kerner JK, Denkert C, Yuan Y, AbdulJabbar K, Wienert S, Savas P, Voorwerk L, Beck AH, Madabhushi A, Hartman J, Sebastian MM, Horlings HM, Hudecek J, Ciompi F, Moore DA, Singh R, Roblin E, Balancin ML, Mathieu MC, Lennerz JK, Kirtani P, Chen IC, Braybrooke JP, Pruneri G, Demaria S, Adams S, Schnitt SJ, Lakhani SR, Rojo F, Comerma L, Badve SS, Khojasteh M, Symmans WF, Sotiriou C, Gonzalez-Ericsson P, Pogue-Geile KL, Kim RS, Rimm DL, Viale G, Hewitt SM, Bartlett JMS, Penault-Llorca F, Goel S, Lien HC, Loibl S, Kos Z, Loi S, Hanna MG, Michiels S, Kok M, Nielsen TO, Lazar AJ, Bago-Horvath Z, Kooreman LFS, van der Laak JAWM, Saltz J, Gallas BD, Kurkure U, Barnes M, Salgado R, Cooper LAD, International Immuno-Oncology Biomarker Working Group. Report on computational assessment of Tumor Infiltrating Lymphocytes in solid tumors from the International Immuno-Oncology Biomarker Working group. NPJ Breast Cancer 6:16, 2020. e-Pub 2020. PMID: 32411818.
22. Groisberg R, Roszik J, Conley AP, Lazar AJ, Portal DE, Hong DS, Naing A, Herzog CE, Somaiah N, Zarzour MA, Patel S, Brown RE, Subbiah V. Genomics, morphoproteomics, and treatment patterns of alveolar soft part sarcoma patients and response to multiple experimental therapies. Mol Cancer Ther 19(5):1165-1172, 2020. PMID: 32127467.
23. Cortés-Ciriano I, Lee JJ, Xi R, Jain D, Jung YL, Yang L, Gordenin D, Klimczak LJ, Zhang CZ, Pellman DS; PCAWG Structural Variation Working Group, Park PJ; PCAWG Consortium. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet 52(3):331-341, 2020. e-Pub 2020. PMID: 32025003.
24. Carrot-Zhang J, Chambwe N, Damrauer JS, Knijnenburg TA, Robertson AG, Yau C, Zhou W, Berger AC, Huang KL, Newberg J, Mashl RJ, Romanel A, Sayaman RW, Demichelis F, Felau I, Frampton G, Han S, Hoadley KA, Kemal A, Laird PW, Lazar AJ, Le X, Oak N, Shen H, Wong CK, Zenklusen JC, Ziv E, Cancer Genome Atlas Analysis Network, Cherniack AD, Beroukhim R. Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer. Cancer Cell 37(5):639-654, 2020. PMID: 32396860.
25. Hudeček J, Voorwerk L, van Seijen M, Nederlof I, de Maaker M, van den Berg J, van de Vijver KK, Sikorska K, Adams S, Demaria S, Viale G, Nielsen TO, Badve SS, Michiels S, Symmans WF, Sotiriou C, Rimm DL, Hewitt SM, Denkert C, Loibl S, Loi S, Bartlett JMS, Pruneri G, Dillon DA, Cheang MCU, Tutt A, Hall JA, Kos Z, Salgado R, Kok M, Horlings HM; International Immuno-Oncology Biomarker Working Group. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. NPJ Breast Cancer 6(15), 2020. PMID: 32436923.
26. Merino DM, McShane LM, Fabrizio D, Funari V, Chen SJ, White JR, Wenz P, Baden J, Barrett JC, Chaudhary R, Chen L, Chen WS, Cheng JH, Cyanam D, Dickey JS, Gupta V, Hellmann M, Helman E, Li Y, Maas J, Papin A, Patidar R, Quinn KJ, Rizvi N, Tae H, Ward C, Xie M, Zehir A, Zhao C, Dietel M, Stenzinger A, Stewart M, Allen J, TMB Harmonization Consortium. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. J Immunother Cancer 8(1):e000147, 2020. PMID: 32217756.
27. PCAWG Transcriptome Core Group, Calabrese C, Davidson NR, Demircioğlu D, Fonseca NA, He Y, Kahles A, Lehmann KV, Liu F, Shiraishi Y, Soulette CM, Urban L, Greger L, Li S, Liu D, Perry MD, Xiang Q, Zhang F, Zhang J, Bailey P, Erkek S, Hoadley KA, Hou Y, Huska MR, Kilpinen H, Korbel JO, Marin MG, Markowski J, Nandi T, Pan-Hammarström Q, Pedamallu CS, Siebert R, Stark SG, Su H, Tan P, Waszak SM, Yung C, Zhu S, Awadalla P, Creighton CJ, Meyerson M, Ouellette BFF, Wu K, Yang H; PCAWG Transcriptome Working Group, Brazma A, Brooks AN, Göke J, Rätsch G, Schwarz RF, Stegle O, Zhang Z; PCAWG Consortium. Genomic basis for RNA alterations in cancer. Nature 578(7793):129-136, 2020. PMID: 32025019.
28. Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN, Islam SMA, Lopez-Bigas N, Klimczak LJ, McPherson JR, Morganella S, Sabarinathan R, Wheeler DA, Mustonen V; PCAWG Mutational Signatures Working Group, Getz G, Rozen SG, Stratton MR; PCAWG Consortium. The repertoire of mutational signatures in human cancer. Nature 578(7793):94-101, 2020. PMID: 32025018.
29. Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RI, Lin Z, Feuerbach L, Sabarinathan R, Madsen T, Kim J, Mularoni L, Shuai S, Lanzós A, Herrmann C, Maruvka YE, Shen C, Amin SB, Bandopadhayay P, Bertl J, Boroevich KA, Busanovich J, Carlevaro-Fita J, Chakravarty D, Chan CWY, Craft D, Dhingra P, Diamanti K, Fonseca NA, Gonzalez-Perez A, Guo Q, Hamilton MP, Haradhvala NJ, Hong C, Isaev K, Johnson TA, Juul M, Kahles A, Kahraman A, Kim Y, Komorowski J, Kumar K, Kumar S, Lee D, Lehmann KV, Li Y, Liu EM, Lochovsky L, Park K, Pich O, Roberts ND, Saksena G, Schumacher SE, Sidiropoulos N, Sieverling L, Sinnott-Armstrong N, Stewart C, Tamborero D, Tubio JMC, Umer HM, Uusküla-Reimand L, Wadelius C, Wadi L, Yao X, Zhang CZ, Zhang J, Haber JE, Hobolth A, Imielinski M, Kellis M, Lawrence MS, von Mering C, Nakagawa H, Raphael BJ, Rubin MA, Sander C, Stein LD, Stuart JM, Tsunoda T, Wheeler DA, Johnson R, Reimand J, Gerstein M, Khurana E, Campbell PJ, López-Bigas N; PCAWG Drivers and Functional Interpretation Working Group; PCAWG Structural Variation Working Group, Weischenfeldt J, Beroukhim R, Martincorena I, Pedersen JS, Getz G; PCAWG Consortium. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578(7793):102-111, 2020. PMID: 32025015.
30. Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD; PCAWG Evolution & Heterogeneity Working Group, Spellman PT, Wedge DC, Van Loo P; PCAWG Consortium. The evolutionary history of 2,658 cancers. Nature 578(7793):122-128, 2020. PMID: 32025013.
31. Li Y, Roberts ND, Wala JA, Shapira O, Schumacher SE, Kumar K, Khurana E, Waszak S, Korbel JO, Haber JE, Imielinski M; PCAWG Structural Variation Working Group, Weischenfeldt J, Beroukhim R, Campbell PJ; PCAWG Consortium. Patterns of somatic structural variation in human cancer genomes. Nature 578(7793):112-121, 2020. PMID: 32025012.
32. Rubanova Y, Shi R, Harrigan CF, Li R, Wintersinger J, Sahin N, Deshwar A; PCAWG Evolution and Heterogeneity Working Group, Morris Q; PCAWG Consortium. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nat Commun 11(1):731, 2020. PMID: 32024834.
33. Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med 143(10):1203-1211, 2019. e-Pub 2019. PMID: 30969158.
34. Bonvalot S, Rutkowski PL, Thariat J, Carrère S, Ducassou A, Sunyach MP, Agoston P, Hong A, Mervoyer A, Rastrelli M, Moreno V, Li RK, Tiangco B, Herraez AC, Gronchi A, Mangel L, Sy-Ortin T, Hohenberger P, Thierry de Baère T, Le Cesne A, Helfre S, Saada-Bouzid E, Borkowska A, Rodica A, Co A, MD25, Gebhart M, Kantor G, Montero A, Loong HH, Vergés R, Lapeire L, Dema S, Kacso G, Austen L, Moureau-Zabotto L, Servois V, Wardelmann E, Terrier P, Lazar AJ, Bovée JVMG, Le Péchoux C, Papai Z. Phase II/III randomized trial of first-in-class radio-enhancer hafnium oxide nanoparticle NBTXR3 plus radiotherapy vs radiotherapy alone in patients with locally advanced soft tissue sarcoma: Act.In.Sarc. Lancet Oncol 20(8):1148-1159, 2019. PMID: 31296491.
35. Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres-Cabala CA, Efstathiou E, Hoang AG, Wong MK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba I, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Clin Cancer Res 25(11):3455-3467, 2019. e-Pub 2019. PMID: 30808776.
36. Merker JD, Devereaux K, Iafrate AJ, Kamel-Reid S, Kim AS, Moncur JT, Montgomery SB, Nagarajan R, Portier BP, Routbort MJ, Smail C, Surrey LF, Vasalos P, Lazar AJ, Lindeman NI. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays. Arch Pathol Lab Med 143(4):463-471, 2019. e-Pub 2018. PMID: 30376374.
37. Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA. Long-term outcomes for patients with desmoid fibromatosis treated with radiation therapy: an effective treatment but with poorer outcomes among young patients. Int J Radiat Oncol Biol Phys 103(5):1167-1174, 2019. e-Pub 2018. PMID: 30552963.
38. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo, BA. Extraskeletal osteosarcomas: a case made for combined modality local therapy with radiation and surgery. Am J Clin Oncol 42(3):238-242, 2019. PMID: 30614820.
39. Carugo A, Minelli R, Sapio L, Soeung M, Carbone F, Robinson FS, Tepper J, Ziheng C, Lovisa S, Svelto M, Amin S, Srinivasan S, Del Poggetto E, Loponte S, Puca F, Dey P, Malouf GG, Su X, Li L, Lopez-Terrada D, Rakheja D, Lazar AJ, Netto G, Rao P, Sgambato A, Maitra A, Tripathi D, Walker C, Karam J, Heffernan TP, Viale A, Roberts CWM, Msaouel P, Tannir N, Draetta GF, Genovese G. TP53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors. Cancer Cell 35(2):204-220.e9, 2019. PMID: 30753823.
40. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu W-J, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman SE, Kageyama R, Wells DK, Patrick Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald JE, Simpson L, Burton EM, Posada L, Haydu LE, Lazar AJ., Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto VG, Sharma P, Allison JP, Tetzlaff MT, Wargo JA. Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma. Nat Med 24(11):1649-1654, 2018. e-Pub 2018. PMID: 30297909.
41. Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med 24(12):1804-1808, 2018. PMID: 30420754.
42. Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC. Circulating Tumor DNA Analysis in Patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Arch Pathol Lab Med 142(10):1242-1253, 2018. e-Pub 2018. PMID: 29504834.
43. Kim G, Kurnit KC, Djordjevic B, Singh C, Munsell MF, Wang WL, Lazar AJ, Zhang W, Broaddus R. Nuclear β-Catenin Localization and Mutation of the CTNNB1 Gene: A Context-Dependent Association. Mod Pathol 31(10):1553-1559, 2018. e-Pub 2018. PMID: 29795437.
44. Chen H, Luthra R, Patel KP, Routbort M, Rashid A, Roy-Chowdhuri S, Lazar AJ, Broaddus R, Manekia J, Singh RR, Yemelyanova A.. Challenges in next generation sequencing analysis of somatic mutations in transplant patients. Cancer Genet 226-227:17-22, 2018. e-Pub 2018. PMID: 30005850.
45. Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB; The Cancer Genome Atlas Network, Camargo F, Liang H.. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep 25(5):1304-1317.e5, 2018. PMID: 30380420.
46. Conley AP, Trinh VA, Zobniw CM, Posey K, Martinez JD, Arrieta OG, Wang WL, Lazar AJ, Somaiah N, Roszik J, Patel SR. Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient with Refractory Alveolar Soft Part Sarcoma: A Case Report. J Global Oncol 4:1-6, 2018. e-Pub 2017. PMID: 30241159.
47. Bezrookove V, Nosrati M, Miller III JR, De Semir D, Dar AA, Vosoughi E, Vaquero E, Sucker A, Lazar AJ, Gershenwald JE, Davies MA, Schadendorf D, Kashani-Sabet M. Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma. Clin Cancer Res 24(17):4119-4125, 2018. e-Pub 2018. PMID: 29776954.
48. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 18(1):913, 2018. PMID: 30249211.
49. Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC. Circulating Tumor DNA Analysis in Patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J Clin Oncol 36(16):1631-1641, 2018. e-Pub 2018. PMID: 29504847.
50. McBride MJ, Pulice JL, Nakayama RT, Beird HC, Ingram DR, D’Avino AR, Shern JF, Charville GR, Hornick JL, Garcia-Rivera EM, Araujo D, Tsai J-W, Wang WL, Yeagley M, Wagner AJ, Futreal PA, Khan J, Lazar AJ & Kadoch C. The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell 33(6):1128-1141.e7, 2018. PMID: 29861296.
51. Livingston JA, Wang WL, Tsai JW, Lazar AJ, Leung CH, Lin H, Advani S, Daw N, Santiago-O'Farrill J, Hollomon M, Gordon NB, Kleinerman ES. Analysis of HSP27 and the autophagy marker LC3B+ puncta following preoperative chemotherapy identifies high-risk osteosarcoma patients. Mol Cancer Ther 17(6):1315-1323, 2018. e-Pub 2018. PMID: 29592877.
52. Kwong LN, De Macedo MP, Haydu L, Joon AY, Tetzlaff MT, Calderone TL, Wu CJ, Kwong MK, Roszik J, Hess KR, Davies MA, Lazar AJ, Gershenwald JE. Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas. JCO Precis Oncol 2018:PO.17.00259, 2018.
53. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan BK, Kwaitkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WT, Robertson AG, The Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23(1):313-326.e5, 2018. PMID: 29925010.
54. Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW. The Clinical Behavior of Well Differentiated Liposarcoma can be Extremely Variable: A Retrospective Cohort Study at a Major Sarcoma Center. J Surg Oncol 117(8):1799-1805, 2018. e-Pub 2018. PMID: 29723411.
55. Oba J, Kim S-H, Wang WL, Macedo MP, Carapeto F, McKean MA, Van Arnam J, Eterovic AK, Sen S, Kale CR, Yu X, Haymaker CL, Routbort M, Haydu LE, Bernatchez C, Lazar AJ, Grimm EA, Hong DS, and Woodman SE. Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma. JCO Precision Oncol 2018:PO.18.00055, 2018. e-Pub 2018. PMID: 30094412.
56. Romano G, Chen PL, Song P, McQuade JL, Liang RJ, Liu M, Roh W, Duose DY, Carapeto FCL, Li J, Teh JLF, Aplin AE, Chen M, Zhang J, Lazar AJ, Davies MA, Futreal PA, Amaria RN, Zhang DY, Wargo JA, Kwong LN. A pre-existing rare PIK3CAE545K subpopulation confers clinical resistance to MEK plus CDK4/6 inhibition in NRAS melanoma and is dependent on S6K1 signaling. Cancer Discov 8(5):556-567, 2018. e-Pub 2018. PMID: 29496665.
57. Somaiah N, Beird H, Shaw K, Song J, Barbo JA, Wang WL, Conley AP, Ravi V, Chen K, Eterovic K, Lazar AJ, Hwu P, Futreal PA, Meric-Bernstam F, Hong DS. Targeted next generation sequencing in well-differentated/dedifferentiated liposarcoma (WD/DD LPS) reveals novel gene alterations. Oncotarget 9(28):19891-19899, 2018. PMID: 29731991.
58. Cooper LA, Demicco EG, Saltz JH, Powell RT, Rao A, Lazar AJ. Pan-Cancer Insights from The Cancer Genome Atlas: The Pathologist’s Perspective. J Pathol 244(5):512-524, 2018. PMID: 29288495.
59. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, MC3 Working Group, Cancer Genome Atlas Research Network, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173(2):371-385.e18, 2018. PMID: 29625053.
60. Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, Cancer Genome Atlas Network, Stuart JM, Benz CC, Laird PW. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173(2):291-304.e6, 2018. PMID: 29625048.
61. Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, Cancer Genome Atlas Research Network, Weinstein JN, Mills GB, Levine DA, Akbani R. A comprehensive Pan-Cancer molecular study of gynecologic and breast cancers. Cancer Cell 33(4):690-705.e9, 2018. e-Pub 2018. PMID: 29622464.
62. Gao Q, Liang WW, Foltz SM, Mutharasu G, Jayasinghe RG, Cao S, Liao WW, Reynolds SM, Wyczalkowski MA, Yao L, Yu L, Sun SQ, Fusion Analysis Working Group, Cancer Genome Atlas Research Network, Chen K, Lazar AJ, Fields RC, Wendl MC, Van Tine BA, Vij R, Chen F, Nykter M, Shmulevich I, Ding L. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep 23(1):227-238.e3, 2018. PMID: 29617662.
63. Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich L. The Immune Landscape of Cancer. Immunity 48(4):812-830.e14, 2018. e-Pub 2018. PMID: 29628290.
64. Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK, Cancer Genome Atlas Research Network, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C. Genomic, pathway network, and immunologic features distinguishing squamous carcinomas. Cell Rep 23(1):194-212.e6, 2018. PMID: 29617660.
65. Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang LB, Zhou DC, Liu D, Cao S, Kim YW, Koire A, McMichael JF, Hucthagowder V, Kim TB, Hahn A, Wang C, McLellan MD, Al-Mulla F, Johnson KJ, Cancer Genome Atlas Research Network, Lichtarge O, Boutros PC, Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dipersio JF, Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L. Pathogenic germline variants in 10,389 adult cancers. Cell 173(2):355-370.e14, 2018. PMID: 29625052.
66. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Cancer Genome Atlas Research Network, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173(2):321-337.e10, 2018. PMID: 29625050.
67. Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, The Cancer Genome Atlas Network, Xie W, Yang D. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell 33(4):706-720.e9, 2018. e-Pub 2018. PMID: 29622465.
68. Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen Hu, Sun Y, Yao F, Li J, Zhang H, Liu J, Shriver CD, Hu H, The Cancer Genome Atlas Research Network, Piwnica-Worms H, Ma Li, Liang H. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell Rep 23(1):213-226.e3, 2018. PMID: 29617661.
69. Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, The Cancer Genome Atlas Research Network, Monnat Jr. RJ, Xiao Y, Wang C. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23(1):239-254, 2018. PMID: 29617664.
70. Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi PL, Wang Y, Cheng F, Tan L, Mojumdar K, Du D, Ge Z, Li J, Thomas GV, Birsoy K, Liu L, Zhang H, Zhao Z, Marchand C, Weinstein JN, The Cancer Genome Atlas Research Network, Bathe OF, Liang H. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep 23(1):255-269.e4, 2018. PMID: 29617665.
71. Jayasinghe RG, Cao S, Gao Q, Wendl MC, Vo NS, Reynolds SM, Zhao Y, Climente-González H, Chai S, Wang F, Varghese R, Huang M, Liang WW, Wyczalkowski MA, Sengupta S, Li Z, Payne SH, Fenyö D, Miner JH, Walter MJ, The Cancer Genome Atlas Research Network, Vincent B, Eyras E, Chen K, Shmulevich I, Chen F, Ding L. Systematic Analysis of Splice-Site-Creating Mutations in Cancer. Cell Rep 23(1):270-281.e3, 2018. PMID: 29617666.
72. Seiler M, Peng S, Agrawal AA, Palacino J, Teng T, Zhu P, Smith PG, The Cancer Genome Atlas Research Network, Buonamici S, Yu L. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types. Cell Rep 23(1):282-296.e4, 2018. PMID: 29617667.
73. Chiu HS, Somvanshi S, Patel E, Chen TW, Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS, The Cancer Genome Atlas Research Network, Sood AK, Gunaratne PH, Sumazin P. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context. Cell Rep 23(1):297-312.e12, 2018. PMID: 29617668.
74. Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology. J Am Acad Dermatol 80(1):189-207, 2018. e-Pub 2018. PMID: 29689323.
75. Schaub FX, Dhankani V, Berger AC, Trivedi M, Richardson AB, Shaw R, Zhao W, Zhang X, Ventura A, Liu Y, Ayer DE, Hurlin PJ, Cherniack AD, Eisenman RN, Bernard B, Grandori C; The Cancer Genome Atlas Network. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across The Cancer Genome Atlas. Cell Syst 6(3):282-300.e2, 2018. PMID: 29596783.
76. Ellrott K, Bailey MH, Saksena G, Covington KR, Kandoth C, Stewart C, Hess J, Ma S, Chiotti KE, McLellan M, Sofia HJ, Hutter C, Getz G, Wheeler D, Ding L; MC3 Working Group; The Cancer Genome Atlas Network. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. Cell Syst 6(3):271-281.e7, 2018. PMID: 29596782.
77. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97-103, 2018. e-Pub 2017. PMID: 29097493.
78. The Cancer Genome Atlas Research Network, Demicco EG, Ding L, Ladanyi M, Lazar AJ, Singer S. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell 171(4):950-965.e28, 2017. PMID: 29100075.
79. Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol 18(11):1493-1501, 2017. PMID: 28988646.
80. Wagner MJ, Vinod R, Patel S, Lazar AJ, Ludwig JA, Conley AP, Ratan R, Zarzour MA, Somaiah N, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin (Vid) for Initial Treatment of Ewing Sarcoma in Adults. Oncologist 22(10):1271-1277, 2017. PMID: 28710342.
81. May CD, Bolshakov S, Landers SM, Ingram DR, Ma XY, Kivlin CM, Watson KL, Al Sannaa GA, Bhalla A, Wang WL, Lazar AJ, Torres KE. Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma. Cancer Biol Ther 18(10):816-826, 2017. e-Pub 2017. PMID: 29099264.
82. Kasper B, Baumgarten C, Garcia J, Bonvalot S, Haas R, Haller F, Hohenberger P, Penel N, Messiou C, van der Graaf WT, Gronchi A; Desmoid Working Group. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol 28(10):2399-2408, 2017. PMID: 28961825.
83. Semenova G, Stepanova DS, Dubyk C, Deyev SM, Lazar AJ, and Chernoff J. Targeting Group I p21-Activated Kinases in Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Oncogene 36(38):5421-5431, 2017. e-Pub 2017. PMID: 28534510.
84. Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal PA, Lazar AJ, Patel SR, Conley AP. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes. Clin Sarcoma Res 7(11), 2017. e-Pub 2017. PMID: 28630682.
85. Kim DW, Haydu LE, Joon AY, Bassett RL, Siroy AE, Tetzlaff MT, Routbort MJ, Amaria RN, Wargo JA, McQuade JL, Kemnade J, Hwu P, Woodman SE, Roszik J, Kim KB, Gershenwald JE, Lazar AJ, Davies MA. Clinicopathological features and clinical outcomes associated with TP53 and BRAF non-V600 mutations in cutaneous melanoma patients. Cancer 123(8):1372-1381, 2017. e-Pub 2016. PMID: 27911979.
86. Roh W, Chen PL, Reuben A, Spencer CN, Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy SM, Gumbs C, Little L, Chang Q, Chen WS, Wani K, De Macedo MP, Chen E, Austin-Breneman JL, Jiang H, Roszik J, Tetzlaff MT, Davies MA, Gershenwald JE, Tawbi H, Lazar AJ, Hwu P, Hwu WJ, Diab A, Glitza IC, Patel SP, Woodman SE, Amaria RN, Prieto VG, Hu J, Sharma P, Allison JP, Chin L, Zhang J, Wargo JA, Futreal PA. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med 9(379), 2017. PMID: 28251903.
87. Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JA. IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. J Natl Cancer Inst 108(12), 2016. e-Pub 2016. PMID: 27576731.
88. Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med 213(13):2989-3005, 2016. PMID: 27956588.
89. Charville GW, Varma S, Forgó E, Dumont SN, Zambrano E, Trent JC, Lazar AJ, van de Rijn M. PAX7 expression in rhabdomyosarcoma, related soft-tissue tumors, and small round blue-cell neoplasms. Am J Surg Pathol 40(10), 2016. PMID: 27526298.
90. Roszik J, Haydu LE, Hess KR, Oba J, Joon AY, Siroy AE, Karpinets TV, Stingo FC, Baladandayuthapani V, Tetzlaff MT, Wargo JA, Chen K, Forget MA, Haymaker CL, Chen JQ, Meric-Bernstam F, Eterovic AK, Shaw KR, Mills GB, Gershenwald JE, Radvanyi LG, Hwu P, Futreal PA, Gibbons DL, Lazar AJ, Bernatchez C, Davies MA, Woodman SE. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC Med 14(1):168, 2016. e-Pub 2016. PMID: 27776519.
91. Kattan MW, Hess KR, Amin M, Lu Y, Moons KG, Gershenwald JE, Gimotty PA, Guinney J, Halabi S, Lazar AJ, Mahar A, Patel T, Sargent DJ, Weiser MR, Compton C, & Members of the AJCC Precision Medicine Core. American Joint Committee on Cancer Acceptance Criteria for Inclusion of Risk Models for Individualized Prognosis in the Practice of Precision Medicine. CA Cancer J Clin 66(5):370-4, 2016. e-Pub 2016. PMID: 26784705.
92. Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, Van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC,Lazar AJ, Bovée JV. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29(9), 2016. e-Pub 2016. PMID: 27573709.
93. El Beaino ka M. Araujo DM, Gopalakrishnan V, Lazar AJ, Lin PP. Prognosis of T1 Synovial Sarcoma Depends Upon Surgery by Oncologic Surgeons. J Surg Oncol 114(4):490-4, 2016. e-Pub 2014. PMID: 27220538.
94. Bird JE, Morse LJ, Feng L, Wang WL, Lin PP, Moon BS, Lazar AJ, Satcher RL, Madewell JE, Lewis VO. Non-radiographic Risk Factors Differentiating Atypical Lipomatous Tumors from Lipomas. Front Oncol 6(6):197, 2016. e-Pub 2016. PMID: 27713864.
95. Bill KL, Garnett J, Meaux I, Ma X, Creighton CJ, Bolshakov S, Barriere C, Debussche L, Lazar AJ, Prudner BC, Casadei L, Braggio D, Lopez G, Zewdu A, Bid H, Lev D, Pollock RE. SAR405838: A novel and potent inhibitor of the MDM2:p53 axis for the treatment of dedifferentiated liposarcoma. Clin Cancer Res 22(5):1150-60, 2016. e-Pub 2015. PMID: 26475335.
96. Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres-Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li HS, Kwong LN, Heffernan TP, Hu J, Bassett RL, Bosenberg MW, Woodman SE, Overwijk WW, Lizée G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi L, Davies MA, Hwu P. Loss of PTEN Promotes Resistence to T-Cell Mediated Immunotherapy. Cancer Discov 6(2):202-16, 2016. e-Pub 2015. PMID: 26645196.
97. Jamshidi F, Bashashati A, Shumansky K, Dickson B, Gogkoz N, Wunder JS, Andrulis I, Lazar AJ, Shah S, Huntsman DG, Nielsen TO. The genomic landscape of epithelioid sarcoma cell lines and tumor specimens. J Pathol 238(1):63-73, 2016. PMID: 26365879.
98. Wardelmann E, Haas RL, Bovée JVMG , Terrier P, Lazar AJ, Messiou C, LePechoux C, Hartmann W, Collin F, Fisher C, Mechtersheimer G, DeiTos AP, Gronchi A, Bonvalot S. Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. Eur J Cancer 53:84-95, 2016. PMID: 26700077.
99. Roszik J, Wu CJ, Siroy AE, Lazar AJ, Davies MA, Woodman SE, Kwong LN. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression. Sci Rep 6:19649, 2016. e-Pub 2016. PMID: 26787600.
100. Messiou C, Bonvalot S, Gronchi A, Vanel D, Meyer M, Robinson P, Morosi C, Bloem JL, Terrier PH, Lazar AJ, Le Péchoux C, Wardelman E, Winfield JM, Boulet B, Bovée J, Haas RL. Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC - STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging. Eur J Cancer 56:37-44, 2016. e-Pub 2016. PMID: 26802529.
101. Verschoor AJ, Cleton-Jansen A-M, Wijers-Koster P, Coffin CM, Lazar AJ, Nout RA, Rubin BP, Gelderblom H, Bovée JVMG. Radiation induced sarcomas occurring in desmoid-type fibromatosis are not always derived from the primary tumor. Am J Surg Pathol 39(12):1701-7, 2015. PMID: 26414222.
102. Rai K, Akdemir KC, Kwong LN, Fiziev P, Wu CJ, Keung EZ, Sharma S, Samant NS, Williams M, Axelrad JB, Shah A, Yang D, Grimm EA, Barton MC, Milton DR, Heffernan TP, Horner JW, Ekmekcioglu S, Lazar AJ, Ernst J, Chin L. Dual Roles of RNF2 in Melanoma Progression. Cancer Discov 5(12):1314-27, 2015. e-Pub 2015. PMID: 26450788.
103. Roy-Chowdhuri S, de Melo Gagliato D, Routbort MJ, Patel KP, Singh RR, Broaddus RR, Lazar AJ, Sahin A, Alvarez RH, Moulder S, Wheler JJ, Janku F, Gonzalez-Angulo AM, Chavez-MacGregor M, Valero V, Ueno NT, Mills G, Mendelsohn J, Yao H, Aldape KD, M.D., Luthra R, Meric-Bernstam F. Multigene Clinical Mutational Profiling of Breast Carcinoma using Next Generation Sequencing (NGS). Am J Clin Pathol 144(5):713-21, 2015. PMID: 26486734.
104. Patel NR, Salim AA, Sayeed H, Sarabia SF, Hollingsworth F, Warren M, Jakacky J, Tanas M, Oliveira AM, Rubin BP, Lazar AJ, López-Terrada D, Wang WL. Molecular Characterization of Epithelioid Haemangioendotheliomas Identifies Novel WWTR1-CAMTA1 Fusion Variants. Histopathology 67(5):699-708, 2015. e-Pub 2015. PMID: 25817592.
105. Shang H, Braggio D, Lee YJ, Al Sannaa GA, Creighton CJ, Bolshakov S, Lazar AJ, Lev D, Pollock RE. Targeting the notch pathway: a potential therapeutic approach for desmoid tumors. Cancer 121(22):4088-96, 2015. PMID: 26349011.
106. Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton CJ, Rao P, Hicks J, Man TK, Lau C, Brown AM, Jones SN, Lazar AJ, Ingram D, Lev D, Donehower LA, Yustein JT. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene 34(39):5069-79, 2015. e-Pub 2015. PMID: 25579177.
107. Goswami RS, Patel KP, Singh RR, Meric-Bernstam F, Kopetz ES, Subbiah V, Alvarez RH, Davies MA, Jabbar KJ, Roy-Chowdhuri S, Lazar AJ, Medeiros LJ, Broaddus RR, Luthra R, Routbort MJ. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors. Clin Cancer Res 21(11):2644-51, 2015. e-Pub 2015. PMID: 25695693.
108. The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell 161(7):1681-96, 2015. PMID: 26091043.
109. Gong L, Govan JM, Evans EB, Dai H, Wang E, Lee SW, Lin HK, Lazar AJ, Mills GB, Lin SY. Nuclear PTEN Tumor-Suppressor Functions Through Maintaining Heterochromatin Structure. Cell Cycle 14(14):2323-32, 2015. e-Pub 2015. PMID: 25946202.
110. Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF V600: clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2014. PMID: 25148578.
111. Colombo C, Foo WC, Whiting D, Young ED, Lusby K, Pollock RE, Lazar AJ, Lev D. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center. Histol Histopathol 27(5):641-9, 2012. PMID: 22419028.
112. Shalin SC, Sakharpe A, Lyle S, Lev D, Calonje E, Lazar AJ. P53 Staining Correlates with Tumor Type and Location in Sebaceous Neoplasms. Am J Dermatopathol 34(2):129-35; quiz 136-8, 2012. PMID: 22441365.
113. Shvartsbeyn M, Lazar AJ, Lopez-Terrada D, Meehan SA. Pseudocystic Dermatofibrosarcoma Protuberans: Report of Two Cases and Demonstration of COL1A1-PDGFB Rearrangement. J Cutan Pathol 39(3):356-60, 2012. PMID: 22335595.
114. Dumont SN, Lazar AJ, Bridge JA, Benjamin RS, Trent JC. PAX3/7-FOXO1 Fusion Status in Older Rhabdomyosarcoma Patient Population by Fluorescent In Situ Hybridization. J Cancer Res Clin Oncol 138(2):213-20, 2012. e-Pub 2011. PMID: 22089931.
115. Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, Wang WL, Barahmani N, Okcu MF, Hicks J, Debelenko L, Spunt SL. Liposarcoma in Children and Young Adults: A Multi-Institutional Experience. Pediatr Blood Cancer 57(7):1142-6, 2011. e-Pub 2011. PMID: 21394894.
116. Ghadimi MP, Al-Zaid T, Madewell J, Peng T, Colombo C, Hoffman A, Creighton CJ, Zhang Y, Zhang A, Lazar AJ, Pollock RE, Lev D. Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis. Ann Surg Oncol 18(13):3762-70, 2011. e-Pub 2011. PMID: 21614627.
117. Ghadimi MP, Liu P, Peng T, Bolshakov S, Young ED, Torres KE, Colombo C, Hoffman A, Broccoli D, Hornick JL, Lazar AJ, Pisters P, Pollock RE, Lev D. Pleomorphic liposarcoma: Clinical observations and molecular variables. Cancer 117(23):5359-69, 2011. e-Pub 2011. PMID: 21598240.
118. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of Temozolomide and Bevacizumab in the Treatment of Locally Advanced, Recurrent, and Metastatic Hemangiopericytoma and Malignant Solitary Fibrous Tumor. Cancer 117(21):4939-47, 2011. e-Pub 2011. PMID: 21480200.
119. Xie X, Ghadimi MP, Young ED, Belousov R, Zhu QS, Liu J, Lopez G, Colombo C, Peng T, Reynoso D, Hornick JL, Lazar AJ, Lev D. Combining EGFR and mTOR blockade for the treatment of epithelioid sarcoma. Clin Cancer Res 17(18):5901-12, 2011. e-Pub 2011. PMID: 21821699.
120. Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, Mitsopoulos C, Zvelebil M, Hoch BL, Weiss SW, Debiec-Rychter M, Sciot R, West RB, Lazar AJ, Ashworth A, Reis-Filho JS, Lord CJ, Gerstein MB, Rubin MA, Rubin BP. Identification of a novel WWTR1/CAMTA1 gene fusion in epithelioid hemangioendothelioma by a unique integrative genomic approach. Sci Transl Med 3(98):98ra82, 2011. PMID: 21885404.
121. Hsu A, Esmaeli B, Hayek B, Hossain MG, Shinder R, Lazar AJ, McCarty JH. Analysis of αv Integrin Protein Expression in Squamous Cell Carcinomas of the Human Eyelid Skin. J Cutan Pathol 38(7):570-5, 2011. e-Pub 2011. PMID: 21375561.
122. Torres KE, Liu J, Young E, Huang KL, Ghadimi M, Lusby K, Lazar AJ, Lev D. Expression of 'drugable' tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancer. Histopathology 59(1):156-9, 2011. PMID: 21771036.
123. Swaby MG, Evans HL, Fletcher CD, Prieto VG, Patel KU, Lev DC, Lòpez-Terrada D, Lazar AJ, Wang WL. Dermatofibrosarcoma protuberans (DFSP) with unusual sarcomatous transformation: a series of four cases with molecular confirmation. Am J Dermatopathol 33(4):354-60, 2011. e-Pub 2011. PMID: 21478726.
124. Dayrit JF, Wang WL, Goh SG, Ramdial PK, Lazar AJ, Calonje E. T-cell Rich Angiomatoid Polypoid Pseudolymphoma of the Skin: A Clinicopathological Study of 17 Cases and a Proposed Nomenclature. J Cutan Pathol 38(6):475-82, 2011. e-Pub 2011. PMID: 21352259.
125. Torres KE, Zhu QS, Bill K, Lopez G, Ghadimi MP, Xie X, Young ED, Liu J, Nguyen T, Bolshakov S, Belousov R, Wang S, Lahat G, Liu J, Hernandez B, Lazar AJ, Lev D. Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors. Clin Cancer Res 17(12):3943-55, 2011. e-Pub 2011. PMID: 21540237.
126. Peng T, Zhang P, Liu J, Nguyen T, Bolshakov S, Belousov R, Young ED, Wang X, Brewer K, López-Terrada DH, Oliveira AM, Lazar AJ, Lev D. An experimental model for the study of well differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors. Lab Invest 91(3):392-403, 2011. e-Pub 2010. PMID: 21060307.
127. Carbajal EF, Baranov SA, Manne VG, Young ED, Lazar AJ, Lev DC, Pollock RE, Larin KV. Revealing retroperitoneal liposarcoma morphology using Optical Coherence Tomography. J Biomed Opt 16(2):020502, 2011. PMID: 21361658.
128. Ylipää A, Hunt KK, Yang J, Lazar AJ, Torres KE, Lev DC, Nykter M, Pollock RE, Trent J, Zhang W. Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumor. Cancer 117(2):380-9, 2011. e-Pub 2010. PMID: 20818650.
129. Hu Q, Gao F, Tian W, Ruteshouser EC, Wang Y, Lazar AJ, Stewart J, Strong LC, Behringer RR, Huff V. Wt1 ablation and Igf2-up-regulation in mice result in Wilms tumors with activated pERK1/2. J Clin Invest 121(1):174-83, 2011. e-Pub 2010. PMID: 21123950.
130. Lahat G, Pingyu Zhang P, Zhu Q-S, Torres K, Ghadimi M, Smith KD, Wang W-L, Lazar AJ, Lev D. Molecular subclassification of unclassified pleomorphic sarcoma (UPS/MFH). Histopathol 59(3):556-61, 2011. PMID: 22034893.
131. Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar AJ, Dicker A, Mills GB, Hung MC, Lev D. Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene 30(4):457-70, 2011. e-Pub 2010. PMID: 20856200.
132. Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL. Epithelioid Inflammatory Myofibroblastic Sarcoma: An Aggressive Intra-Abdominal Variant of Inflammatory Myofibroblastic Tumor with Nuclear Membrane or Perinuclear Alk. Am J Surg Pathol 35(1):135-44, 2011. PMID: 21164297.
133. Lopez G, Torres K, Liu J, Hernandez B, Young E, Belousov R, Bolshakov S, Lazar AJ, Slopis JM, McCutcheon IE, McConkey D, Lev D. Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res 71(1):185-96, 2011. e-Pub 2010. PMID: 21084276.
134. Wang X, Asmann YW, Erickson-Johnson M, Oliveira JL, Zhang H, de Deus Moura R, Lazar AJ, Lev D, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM. High Resolution Genomic Mapping Reveals Consistent Amplification of the Fibroblast Growth Factor Receptor Substrate 2 (FRS2) Gene in Well Differentiated and Dedifferentiated Liposarcoma. Clin Cancer Research 50(11):849-58, 2011. PMID: 21793095.
135. Sakharpe A, Lahat G, Gulamhusein T, Liu P, Bolshakov S, Nguyen T, Zhang P, Belousov R, Young E, Xie X, Rao P, Hornick JL, Lazar AJ, Pollock RE, Lev D. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model. Oncologist 16(4):512-22, 2011. e-Pub 2011. PMID: 21357725.
136. Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ, Hunt KK, Trent JC, Zhang W. Integrated Proteomic and Genomic Analysis Reveals a Novel Mesenchymal to Epithelial Reverting Transition in Leiomyosarcoma through Regulation of Slug. Mol Cell Proteomics 9(11):2405-13, 2010. e-Pub 2010. PMID: 20651304.
137. Weaver J, Rao P, Goldblum JR, Joyce MJ, Turner SL, Lazar AJ, López-Terada D, Tubbs RR, Rubin BP. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?. Mod Pathol 23(10):1301-6, 2010. e-Pub 2010. PMID: 20495536.
138. Powers MP, Wang WL, Hernandez VS, Patel KS, Lev DC, Lazar AJ, López-Terrada DH. Detection of Myxoid Liposarcoma Associated FUS/DDIT3 Rearrangement Variants Including a Newly Identified Breakpoint using an Optimized RT-PCR Assay. Mod Pathol 23(10):1307-15, 2010. e-Pub 2010. PMID: 20581806.
139. Gupta A, Roy S, Lazar AJ, Wang WL, McAuliffe JC, Reynoso D, McMahon J, Taguchi T, Floris G, Debiec-Rychter M, Schoffski P, Trent JA, Debnath J, Rubin BP. Autophagy inhibition and anti-malarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci U S A 107(32):14333-8, 2010. e-Pub 2010. PMID: 20660757.
140. Brown JG, Folpe AL, Rao P, Lazar AJ, Paner GP, Gupta R, Parakh R, Cheville JC, Amin MB. Primary Vascular Tumors and Tumor-like Lesions of the Kidney: A Clinicopathologic Analysis of 25 Cases. Am J Surg Pathol 34(7):942-9, 2010. PMID: 20534992.
141. Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, Lazar AJ, Lev D. Angiosarcoma: Clinical and Molecular Insights. Ann Surg 251(6):1098-1106, 2010. PMID: 20485141.
142. Lahat G, Tuvin D, Wei C, Wang WL, Pollock RE, Anaya DA, Bekele BN, Corely L, Lazar AJ, Pisters PW, Lev D. Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study. Ann Oncol 21(5):1112-20, 2010. e-Pub 2009. PMID: 19875755.
143. Wang S, Ren W, Liu J, Lahat G, Torres K, Lopez G, Lazar AJ, Hayes-Jordan A, Liu K, Bankson J, Hazle JD, Lev D. TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In vivo. Clin Cancer Res 16(9):2591-604, 2010. e-Pub 2010. PMID: 20406839.
144. Rubin BP, Cooper K, Fletcher CD, Folpe AL, Gannon FH, Hunt JL, Lazar AJ, Montag AG, Peabody TD, Pollock RE, Reith JD, Qualman SJ, Rosenberg AE, Weiss SW, Krausz T, Members of the Cancer Committee, College of American Pathologists. Protocol for the Examination of Specimens from Patients with Tumors of Soft Tissue. Arch Pathol Lab Med 134(4):e31-39, 2010. PMID: 20367297.
145. Ostler DA, Prieto VG, Reed JA, Deavers MT, Lazar AJ, Ivan D. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology - an immunohistochemical study of 117 cases. Mod Pathol 23(4):567-73, 2010. e-Pub 2010. PMID: 20118912.
146. Wang WL, Patel KU, Coleman NM, Smith-Zagone MJ, Ivan D, Reed JA, López-Terrada D, Lazar AJ, Prieto VG. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin. Am J Dermatopathol 32(2):149-53, 2010. PMID: 19940748.
147. Rutkowski P, van Glabbeke M, Rankin C, Ruka W, Rubin BP, Debiec-Rychter M, Lazar AJ, Gerderblom H, Sciot R, Lopez-Terrada D, Hohenberger P, van Oosterom A, Schuetze S. Imatinib mesylate in advanced dermatofibrosarcoma protuberans (DFSP)-pooled analysis of two phase II clinical trials. J Clin Oncol 28(10):1772-9, 2010. PMID: 20194851.
148. Ivan D, Prieto VG, Esmaeli B, Wistuba II, Tang X, Lazar AJ. Epidermal Growth Factor Receptor (EGFR) Expression in Periocular and Extraocular Sebaceous Carcinoma. J Cutan Pathol 37(2):231-236, 2010. e-Pub 2009. PMID: 19614729.
149. Hantschke M, Mentzel T, Rütten A, Palmedo G, Calonje E, Lazar AJ, Kutzner H. Cutaneous Clear Cell Sarcoma: a clinicopathologic, immunohistochemical and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol 34(2):216-222, 2010. PMID: 20087159.
150. Lahat G, Zhu QS, Huang KL, Wang S, Bolshakov S, Liu J, Torres K, Langley RR, Lazar AJ, Hung MC, Lev D. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One 5(4):e10105, 2010. e-Pub 2010. PMID: 20419128.
151. Lazar AJ, Lahat G, Myers SE, Smith KD, Zou C, Wang WL, Lopez-Terrada D, Lev D. Validation of potential therapeutic targets in Alveolar Soft Part Sarcoma: an immunohistochemical study utilizing tissue microarray. Histopathology 55(6):750-5, 2009. PMID: 20002771.
152. Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, Prieto VG, Aldape K, Mills GB, Gershenwald JE. Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res 15(24):7538-7546, 2009. PMID: 19996208.
153. Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 22(11):1446-56, 2009. e-Pub 2009. PMID: 19718013.
154. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Outcome of Locally Recurrent and Metastatic Angiosarcoma. Ann Surg Oncol 115(13):2971-9, 2009. e-Pub 2009. PMID: 19551444.
155. Wang WL, Mayordomo E, Zhang W, Hernandez VS, Tuvin D, Garcia L, Lev DC, Lazar AJ, López-Terrada D. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod Pathol 22(9):1201-1209, 2009. e-Pub 2009. PMID: 19561568.
156. Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Lev D. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol 16(9):2579-86, 2009. e-Pub 2009. PMID: 19557478.
157. Woodman SE, Trent JC, Stemke-Hale K, Lazar AJ, Pricl S, Pavan GM, Fermeglia M, Gopal YN, Yang D, Podoloff DA, Ivan D, Kim KB, Papadopoulos N, Hwu P, Mills GB, Davies MA. Activity of Dasatinib Against L576P Kit Mutant Melanoma: Molecular. Cellular, and Clinical Correlates. Mol Cancer Ther 8(8):2079-85, 2009. e-Pub 2009. PMID: 19671763.
158. Blazer DG, Lazar AJ, Xing Y, Askew RL, Feig BW, Pisters PW, Pollock RE, Lev D, Hunt KK, Cormier JN. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. Cancer 115(13):2971-9, 2009. PMID: 19402173.
159. Pomahac B, Garcia JA, Lazar AJ, Tilney N, Orgill DP. The skin allograft revisited: a potentially permanent wound coverage option in the critically ill patient. Plast Reconstr Surg 123(6):1755-8, 2009. PMID: 19483575.
160. Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 249(6):1014-22, 2009. PMID: 19474676.
161. Zou CY, Smith KD, Zhu QS, Liu J, McCutcheon IE, Slopis JM, Meric-Bernstam F, Peng Z, Bornmann WG, Mills GB, Lazar AJ, Pollock RE, Lev D. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther 8(5):1157-68, 2009. e-Pub 2009. PMID: 19417153.
162. Wang WL, Hornick JL, Mallipeddi R, Zelger BG, Rother JD, Yang D, Lev DC, Trent JC, Prieto VG, Brenn T, Robson A, Calonje E, Lazar AJ. Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: a series of 5 cases with molecular analysis. Am J Dermatopathol 31(3):297-300, 2009. PMID: 19384074.
163. Lahat G, Lazar AJ, Wang X, Wang WL, Zhu QS, Hunt KK, Pollock RE, Lev D. Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas. Clin Cancer Res 15(8):2637, 2009. e-Pub 2009. PMID: 19351758.
164. Yang D, Wang S, Brooks C, Dong Z, Schoenlein PV, Kumar V, Ouyang X, Xiong H, Lahat G, Hayes-Jordan A, Lazar AJ, Pollock R, Lev D, Liu K. IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor-initiated Apoptosis via Repression of FLICE-like Protein Expression. Cancer Res 69(3):1080-8, 2009. e-Pub 2009. PMID: 19155307.
165. Weaver J, Goldblum JR, Turner S, Tubbs RR, Wang WL, Lazar AJ, Rubin BP. Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma. Mod Pathol 22(1):66-70, 2009. e-Pub 2008. PMID: 18836421.
166. Mito JK, Riedel RF, Dodd L, Lahat G, Lazar AJ, Dodd RD, Stangenberg L, Eward WC, Hornicek FJ, Yoon SS, Brigman BE, Jacks T, Lev D, Mukherjee S, Kirsch DG. Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One 4(11):e8075, 2009. e-Pub 2009. PMID: 19956606.
167. Quintás-Cardama A, Lazar AJ, Woodman SE, Kim K, Ross M, Hwu P. Complete Response of Stage IV Anal Mucosal Melanoma Expressing KIT V560D to the multikinase inhibitor sorafenib. Nat Clin Pract Oncol 5(12):737-40, 2008. e-Pub 2008. PMID: 18936790.
168. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Dal Cin P, Araujo DM, Lev DC, López-Terrada D, Lazar AJ. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol 21(11):1303-10, 2008. e-Pub 2008. PMID: 18587326.
169. Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173(5):1518-27, 2008. e-Pub 2008. PMID: 18832571.
170. Lahat G, Tuvin D, Wei C, Anaya DA, Bekele BN, Lazar AJ, Pisters PW, Lev D, Pollock RE. New perspectives for Staging and Prognosis in Soft Tissue Sarcoma. Ann Surg Oncol 15(10):2739-48, 2008. e-Pub 2008. PMID: 18521685.
171. Yang J, Du X, Lazar AJ, Pollock R, Hunt K, Chen K, Hao X, Trent J, Zhang W. Genetic aberrations of gastrointestinal stromal tumors. Cancer 113(7):1532-43, 2008. PMID: 18671247.
172. Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG, Lazar AJ, Gershenwald JE, Mills GB. A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99(8):1265-8, 2008. e-Pub 2008. PMID: 18813315.
173. Rothberg BE, Moeder CB, Kluger H, Halaban R, Elder DE, Murphy GF, Lazar AJ, Prieto V, Duncan LM, Rimm DL. Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. Mod Pathol 21(9):1121-9, 2008. e-Pub 2008. PMID: 18552823.
174. Jin Z, Lahat G, Korchin B, Nguyen T, Zhu QS, Wang X, Lazar AJ, Trent J, Pollock RE, Lev D. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin Cancer Res 14(16):5033-42, 2008. PMID: 18698021.
175. McAuliffe JC, Wang WL, Pavan GM, Pricl S, Yang D, Chen SS, Lazar AJ, Pollock RE, Trent JC. Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors. Mol Oncol 2(2):161-3, 2008. e-Pub 2008. PMID: 19383335.
176. Diwan AH, Skelton HG, Horenstein MG, Kelly DR, Barrett TL, Bussian AH, Sanders DY, Lazar AJ, Prieto VG, Smith KJ. Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity. J Cutan Pathol 35(7):647-50, 2008. e-Pub 2008. PMID: 18201229.
177. Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, Lev D, Lyle S, Calonje E, Lazar AJ. Site and Tumor Type Predicts DNA Mismatch Repair Status in Cutaneous Sebaceous Neoplasia. Am J Surg Pathol 32(6):936-42, 2008. PMID: 18551751.
178. Robson A, Lazar AJ, Ben Nagi J, Hanby A, Grayson W, Feinmesser M, Granter SR, Seed P, Warneke CL, McKee PH, Calonje E. Primary Cutaneous Apocrine Carcinoma: A Clinico-pathological Analysis of 24 Cases. Am J Surg Pathol 32(5):682-690, 2008. PMID: 18347508.
179. Ren W, Korchin B, Zhu QS, Wei C, Dicker A, Heymach J, Lazar AJ, Pollock RE, Lev D. Epidermal growth factor receptor (EGFR) blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma (STS) cell growth in vitro and in vivo. Clin Cancer Res 14(9):2785-2795, 2008. PMID: 18451246.
180. Uzquiano MC, Prieto VG, Nash JW, Ivan DS, Gong Y, Lazar AJ, Diwan AH. Metastatic Basal Cell Carcinoma Exhibits Reduced Actin Expression. Mod Pathol 21(5):540-3, 2008. e-Pub 2008. PMID: 18223552.
181. Euscher ED, Deavers MT, Lopez-Terrada D, Lazar AJ, Silva EG, Malpica A. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol 32(2):219-228, 2008. PMID: 18223324.
182. Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, López-Terrada D. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all DFSP Cases when investigated by newly developed multiplex RT-PCR and FISH Assays. Hum Pathol 39(2):184-193, 2008. e-Pub 2007. PMID: 17950782.
183. Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, Strong L, Chen LL, Choi H, Benjamin RS, Zhang W, Trent JC. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer 122(3):711-8, 2008. PMID: 17943734.
184. Wang Q, Prieto VG, Esmaeli B, Kolda T, Lazar AJ, Ivan D, Diwan AH. Cellular blue nevi of the eyelid: A possible diagnostic pitfall. J Am Acad Dermatol 58(2):257-60, 2008. PMID: 18222322.
185. Rebhun RB, Lazar AJ, Fidler IJ, Gershenwald JE. Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. Clin Exp Metastasis 25(3):191-9, 2008. e-Pub 2008. PMID: 18264782.
186. Ren W, Korchin B, Lahat G, Wei C, Bolshakov S, Nguyen T, Merritt W, Dicker A, Lazar AJ, Sood A, Pollock RE, Lev D. Combined vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft tissue sarcoma. Clin Cancer Res 14(17):5466-75, 2008. PMID: 18765538.
187. Lazar AJ, Das P, Tuvin D, Korchin B, Zhu Q, Jin Z, Warneke CL, Zhang PS, Hernandez V, Lopez-Terrada D, Pisters PW, Pollock RE, Lev D. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma (ASPS): a highly metastatic tumor with prolonged survival. Clin Cancer Res 13(24):7314-7321, 2007. PMID: 18094412.
188. Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S. Epidermodysplasia Verruciformis in the Setting of Graft-Versus-Host Disease. J Am Acad Dermatol 57(5):S78-80, 2007. PMID: 17938030.
189. McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC. Association of Intra-Tumoral Vascular Endothelial Growth Factor Expression and Clinical Outcome for Patients with Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate. Clin Cancer Res 13(22):6727-6734, 2007. PMID: 18006774.
190. Kantrow SM, Ivan D, Williams MD, Prieto VG, Lazar AJ. Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus. Am J Dermatopathol 29(5):462-466, 2007. PMID: 17890915.
191. Khalifeh I, Taraif S, Reed JA, Lazar AJ, Diwan AH, Prieto VG. A Subgroup of Melanocytic Nevi on the Distal Lower Extremity (Ankle) Shares Features of Acral Nevi, Dysplastic Nevi and Melanoma In-Situ: A Potential Misdiagnosis of Melanoma in-Situ. Am J Surg Pathol 29(5):462-466, 2007. PMID: 17592281.
192. Fan YS, Carr RA, Sanders DS, Smith AP, Lazar AJ, Calonje E. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology 51(1):80-86, 2007. PMID: 17593083.
193. Das P, Kotilingam D, Korchin B, Liu J, Yu D, Lazar AJ, Pollock RE, Lev D. High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Cancer 109(11):2323-2333, 2007. PMID: 17429838.
194. Ivan D, Nash JW, Prieto VG, Calonje E, Lyle S, Diwan AH, Lazar AJ. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol 34(6):474-480, 2007. PMID: 17518775.
195. Perna AG, Ostler DA, Ivan D, Lazar AJ, Diwan AH, Prieto VG, Reed JA. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma. J Cutan Pathol 34(5):381-385, 2007. PMID: 17448192.
196. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AJ, Patel SR, Benjamin RS, Pollock RE. Optimizing treatment of desmoid tumors. J Clin Oncol 25(13):1785-91, 2007. PMID: 17470870.
197. Doherty SD, Giancola A, Nash J, Lazar AJ, Duvic M. Papulo-vesicular eruption. Dermatol Online J 13(2):24, 2007. e-Pub 2007. PMID: 17498443.
198. Ivan D, Bengana C, Lazar AJ, Diwan AH, Prieto VG. Merkel Cell Tumor in a Trichilemmal Cyst: Collision or Association?. Am J Dermatopathol 29(2):180-183, 2007. PMID: 17414443.
199. Bieniek R, Lazar AJ, Photopoulos C, Lyle S. Sebaceous tumours contain a subpopulation of cells expressing the keratin 15 stem cell marker. Br J Dermatol 156(2):378-80, 2007. PMID: 17223883.
200. May SA, Jones D, Medeiros LJ, Duvic M, Prieto VG, Lazar AJ. Oral-cutaneous CD4-positive T-cell lymphoma: a study of two patients. Am J Dermatopathol 29(1):62-7, 2007. PMID: 17284964.
201. Nash JW, Barrett TL, Kies M, Ross MI, Sneige N, Diwan AH, Lazar AJ. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications. J Cutan Pathol 34(1):49-54, 2007. PMID: 17214855.
202. Prieto VG, Mourad-Zeidan AA, Melnikova V, Johnson MM, Lopez A, Diwan AH, Lazar AJ, Shen SS, Zhang PS, Reed JA, Gershenwald JE, Raz A, Bar-Eli M. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res 12(22):6709-15, 2006. PMID: 17121890.
203. Liu J, Zhan M, Hannay JA, Das P, Bolshakov SV, Kotilingam D, Yu D, Lazar AJ, Pollock RE, Lev D. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res 4(11):803-10, 2006. e-Pub 2006. PMID: 17077165.
204. Natarajan E, Omobono JD, Guo Z, Hopkinson S, Lazar AJ, Brenn T, Jones JC, Rheinwald JG. A keratinocyte hypermotility/growth arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence. Am J Pathol 168(6):1821-37, 2006. PMID: 16723698.
205. Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG. Examination of mutations in BRAF, NRAS and PTEN in Primary Cutaneous Melanoma. J Invest Dermatol 126(1):154-160, 2006. PMID: 16417231.
206. Lazar AJ, Fletcher CD. Primitive nonneural granular cell tumors of skin: clinicopathologic analysis of 13 cases. Am J Surg Pathol 29(7):927-34, 2005. PMID: 15958858.
207. Haskell HD, Haynes HA, McKee PH, Redston M, Granter SR, Lazar AJ. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin. J Cutan Pathol 32(3):245-50, 2005. PMID: 15701088.
208. Lazar AJ, Calonje E, Grayson W, Dei Tos AP, Mihm MC, Redston M, McKee PH. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol 32(2):148-57, 2005. PMID: 15606674.
209. Lepourcelet M, Tou L, Cai L, Sawada J, Lazar AJ, Glickman JN, Williamson JA, Everett AD, Redston M, Fox EA, Nakatani Y, Shivdasani RA. Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development 132(2):415-27, 2005. e-Pub 2004. PMID: 15604097.
210. Xie Z, Fang M, Rivas MP, Lazar AJ, Sternweis PC, Engebrecht JA, Bankaitis VA. Phospholipase D activity is required for suppression of yeast phosphatidylinositol transfer protein defects. Proc Natl Acad Sci U S A 95(21):12346-51, 1998. PMID: 9770489.
211. Cherry LM, Lazar AJ, Grossberg LA, Balczon R. Kinetochore size variation in mammalian chromosomes: an image analysis study with evolutionary implications. J Cell Sci 92(2):281-9, 1989. PMID: 2674167.
212. Kasper B, Baldini E, Bonvalot S, Callegaro D, Cardona K, Colombo C, Corradini N, Crago A, Dei Tos AP, Dileo P, Elnekave E, Erinjeri JP, Fariba N, Farma J, Ferrari A, Fiore M, Gladdy R, Gounder M, Haas R, Husson O, Kurtz JE, Lazar AJ, Orbach D, Penel N, Ratan R, Raut CP, Roland CL, Schut AR, Sparber-Sauer M, Strauss DC, Van der Graaf W, Vitellaro M, Weiss A, Gronchi A, The Desmoid Tumor Working Group. Current Management of Desmoid Tumors: An Update from the Desmoid Tumor Working Group. JAMA Oncol. PMID: 38900421.

Invited Articles

1. El Beaino M, Roszik J,Livingston JA, Wang WL, Lazar AJ, Amini B, Subbiah V, Lewis V, Conley AP. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology. Curr Oncol Rep 20(5):37, 2018.
2. Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. Surg Oncol Clin N Am 25(4):775-88, 2016. e-Pub 2016. PMID: 27591498.
3. Berri RN, Baumann DP, Madewell JE, Lazar AJ, Pollock RE. Desmoid tumor: Current multidisciplinary approaches. Ann Plast Surg 67(5):551-564, 2011. e-Pub 2011. PMID: 21587055.
4. Hoffman A, Lazar AJ, Pollock RE, Lev D. New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort. Drug Resist Updat 14(1):52-66, 2011. e-Pub 2010. PMID: 21169051.
5. Wang WL, Conley A, Reynoso D, Nolden L, Lazar AJ, George S, Trent JC. Mechanisms of Resistance To Imatinib and Sunitinib in Gastrointestinal Stromal Tumor. Cancer Chemother Pharmacol 67(Suppl 1):S15-24, 2011. e-Pub 2010. PMID: 21181476.
6. Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, Pollock RE, Ludwig JA. Neoadjuvant treatment of soft-tissue sarcoma: A multimodality approach. J Surg Oncol 101(4):327-333, 2010. e-Pub 2010. PMID: 20187067.
7. Shalin SC, Lyle S, Calonje E, Lazar AJ. Sebaceous Neoplasia and the Muir-Torre syndrome: Important Connections with Clinical Implications. Histopathology 56(1):133-147, 2010. PMID: 20055911.
8. Katz D,Lazar AJ, Lev D. Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signaling pathways. Expert Rev Mol Med 11:e30, 2009. e-Pub 2009. PMID: 19835664.
9. Lazar AJ, Hajibashi S, Lev D. Desmoid Tumor: From Surgical Extirpation to Molecular Dissection. Curr Opin Oncol 21(4):352-9, 2009. PMID: 19436199.
10. Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Ewing's sarcoma: standard and experimental treatment options. Curr Treat Options Oncol 10(1-2):126-40, 2009. e-Pub 2009. PMID: 19533369.
11. Yang J, Du X, Chen K, Ylipää A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang W. Genetic Aberrations in Soft Tissue Leiomyosarcoma. Cancer Lett 275(1):1-8, 2009. e-Pub 2008. PMID: 18649996.
12. Liegl B, Hornick JL, Lazar AJ. Contemporary Pathology of Gastrointestinal Stromal Tumor. Hematol Oncol Clin North Am 23(1):49-68, 2009. PMID: 19248970.
13. Lahat G, Lazar AJ, Lev D. Sarcoma epidemiology and etiology; potential environmental and genetic factors. Surg Clin North Am 88(3):451-81, 2008. PMID: 18514694.
14. Kotiligam D, Lazar AJ, Pollock RE, Lev D. Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol 23(1):117-26, 2008. PMID: 17952864.
15. Trent JC, Lazar AJ, Zhang W. Molecular Approaches to Resolve Diagnostic Dilemmas: The Case of Gastrointestinal Stromal Tumor and Leiomyosarcoma. Future Oncol 3(6):629-527, 2007. PMID: 18041915.
16. Lazar AJ, Trent JC, Lev D. Sarcoma Molecular Testing: Diagnosis and Prognosis. Curr Oncol Rep 9(4):309-315, 2007. PMID: 17588356.
17. Perna AG, Prieto VG, Lazar AJ, Ivan D. Primary cutaneous adnexal neoplasms and their metastatic look-alikes. Pathol Case Rev 12(2):61-69, 2007.
18. Lazar AJ, Calonje E, Lyle S. Sebaceous Neoplasia and the Torre-Muir Syndrome. Curr Diagn Pathol 13(4):301-319, 2007.
19. Kotilingam D, Lev DC, Lazar AJ, Pollock RE. Staging Soft Tissue Sarcoma: Evolution and Change. CA Cancer J Clin 56(5):282-291; quiz 314-315, 2006. PMID: 17005597.
20. Haluska FG, Tsao H, Wu H, Haluska FS, Lazar AJ, Goel V. Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 12(2):2103s-2307s, 2006. PMID: 16609049.
21. Lazar AJ, Abruzzo LV, Lee S, Pollock RE, Czerniak BA. Molecular Diagnosis Sarcomas: Chromosomal Translocations in Sarcomas. Arch Pathol Lab Med 130(8):1199-1207, 2006. PMID: 16879024.
22. Lazar AJ. AfCS-Nature Molecule Pages. LPP1, 2005.
23. Lazar AJ. AfCS-Nature Molecule Pages. LPP3, 2005.

Editorials

1. Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, Sapino A, Sasano H, Schnitt S, Sotiriou C, van Diest P, White VA, Lokuhetty D, Cree IA, WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the breast. Histopathology 77(2):181-185, 2020. PMID: 32056259.
2. Lazar AJ. Book Review: Pathology of Melanocytic Disorders, 2nd Edition. Am J Surg Pathol 32(11):1749-50, 2008.

Abstracts

1. Lazar AJ, Fletcher CD. Distinctive dermal clear cell mesenchymal neoplasm: clinicopathologic analysis of five cases. Am J Dermatopathol 26(4):273-9, 2004. PMID: 15249856.

Book Chapters

1. Wang WL, Lazar AJ. Soft Tissue. In: Oncologic Surgical Pathology. Springer: Switzerland, 229-283, 2020.
2. Shalin SC, Lazar AJ. Sebaceous Carcinoma (id: 00469). In: Encyclopedia of Pathology. Springer-Verlag GmbH: Heidelberg, Germany, 2016.
3. Compton CC, Hess KR, Halabi S, Balis UGJ, Gershenwald JE, Gimotty PA, Guinney J, Lazar AJ, Lu Y, Mahar AL, Mariotto, Moons KGM, Patel SG, Sargent DJ, Weiser MR, Kattan MW. Chapter 4: Risk Models for Individualized Prognosis in the Practice of Precision Oncology. In: AJCC Cancer Staging Manual. 8th. Springer: New York, NY, 47-52, 2016.
4. O'Sullivan B, Maki RG, Agulnik M, Patel SG, Lazar AJ, Jones RL, Sturgis EM, Pollock RE. Chapter 40: Soft Tissue Sarcoma of the Head and Neck. In: AJCC Cancer Staging Manual. 8th. Springer: New York, NY, 499-505, 2016.
5. Yoon SS, Maki RG, Asare EA, Cooper K, Hornick JL, Lazar AJ, Keedy VL, Kirsch DG, Madewell JE, Panicek DM, Randall RL, Tedder PS, Pollock RE. Chapter 41: Soft Tissue Sarcoma of the Trunk and Extremities. In: AJCC Cancer Staging Manual. 8th. Springer: New York, NY, 507-515, 2016.
6. Raut CP, Maki RG, Baldini EH, Hornick JL, Lazar AJ, Riedel RF, Tedder PS, Pollock RE. Chapter 42: Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs. In: AJCC Cancer Staging Manual. 8th. Springer: New York, NY, 517-521, 2016.
7. Pollock RE, Maki FG, Baldini EH, Hornick JL, Keedy VL, Lazar AJ, Madewell JE, Raut CP, Tedder PS, Yoon SS. Chapter 44: Soft Tissue Sarcoma of the Retroperitoneum. In: AJCC Cancer Staging Manual. 8th. Springer: New York, NY, 531-537, 2016.
8. Maki RG, Folpe AL, Guadagnolo BA, Keep VL, Lazar AJ, Randall RL, Raut CP, Yoon SS, Pollock RE. Chapter 45: Soft Tissue Sarcoma -- Unusual Histologies and Sites. In: AJCC Cancer Staging Manual. 8th. Springer: New York, NY, 539-545, 2016.
9. Gershenwald JE, Scolyer RA, Hess KR, Thompson JF, Long GV, Ross MI, Lazar AJ, Atkins MB, Balch CM, Barnhill RL, Billmoria KY, Brierly JD, Buzaid AC, Byrd DR, Chapman PB, Cochran AJ, Coit DG, Eggermont AM, Elder DE, Faries MB, Flaherty KT, Garbe C, Gardner JM, Gimotty PA, Halpern AC, Haydu LE, Johnson T, Kirkwood JM, Lee AWM, McArthur GA, Mihm MC, Prieto VG, Sober AJ, Wahl RL, Wong SL, Sondak VK. Chapter 47: Melanoma of the Skin. In: AJCC Cancer Staging Manual. 8th. Springer: New York, NY, 563-585, 2016.
10. Lazar AJ. Chapter 25: The Skin. In: Robbins Basic Pathology, 9th edition. 9th. Saunders (Elsevier): Philadelphia, Pennsylvania, 2015.
11. JDR Reimann, Lazar AJ & Granter SR. Chapter 13: Neoplastic and Non-neoplastic Vascular Tumors. In: Vascular Disease in Atlas of Heart Diseases. 3rd. Mosby (Elsevier): St. Louis, 2014.
12. Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. In: Practical Soft Tissue Pathology. Elsevier: Philadelphia, PA, 2013.
13. Raymond AK, Lazar AJ. Pathologic and Molecular Analysis of Bone Sarcomas. In: MD Anderson Cancer Series: Bone Sarcomas. Springer: Cambridge, MA, 2012.
14. Diwan AH, Lazar AJ. Nevoid Melanoma. In: Clin Lab Med. 3rd, 2011.
15. Powers M*, Zhang W, Czerniak BA, Lopez-Terrada D, Lazar AJ. Chapter 22: The Molecular Pathology of Sarcomas. In: Translational Pathology of Early Cancer. IOS Press BV: Amsterdam, The Netherlands, 475-491, 2011.
16. Foo WC, Lazar AJ. Chapter 4: Pathology of Desmoid Tumors. In: Desmoid Fibromatosis. Springer-Verlag GmbH: Heidelberg, Germany, 2011.
17. Lazar AJ & Murphy GF. Chapter 25, The Skin. In: Pocket Companion to Robbins and Cotran Pathologic Basis of Disease, 8th edition. 8th. Elsevier, 2011.
18. Bowles TL, Ross MI, Lazar AJ. Sarcomas of the Skin. In: Chapter 15: Cancer of the Skin. 2nd. Saunders (Elsevier): New York, 2011.
19. Cangelosi J, Ivan D, Lazar AJ. Chapter 33: Cutaneous Tumors. In: Dermatology: A Pictorial Review. 2nd. McGraw-Hill: New York, NY, 2010.
20. Soft Tissue Sarcoma Committee (Pollock RE, chair; Lazar AJ. Part 5: American Joint Cancer Committee Cancer Staging Manual. In: Musculoskeletal Sites, Soft Tissue Sarcoma. 7th. Greene FL: New York, NY, 2010.
21. Laga AC, Lazar AJ, Haefner H, Granter SR. Chapter 2: Non-infectious inflammatory disorders of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. 2nd. Saunders (Elsevier): Chicago, 2010.
22. Laga AC, Lazar AJ, Granter SR, Haefner HK. Chapter 4: Infectious disorders of the lower genital tract. In: Diagnostic Gynecologic and Obstetric Pathology. 2nd. Saunders (Elsevier): Chicago, 2010.
23. Laga AC, Lazar AJ, Granter SR, Crum CP, Haefner HK. Chapter 5: Benign cysts, rests and adnexal tumors and Cysts of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. 2nd. Saunders (Elsevier): Chicago, 2010.
24. Shalin SC, Lazar AJ. Muir-Torre Syndrome (id: 00450). In: Encyclopedia of Pathology. Springer-Verlag GmbH: Heidelberg, Germany, 2010.
25. Lazar AJ, Nash JW, Diwan AH. Chapter 6: Molecular Dermatopathology, Section III of Foundations. In: Diagnostic Pathology: Cell and Tissue Based Molecular Diagnostic Pathology. Churchill Livingston (Elsevier): Oxford, UK, 2009.
26. Oliveira AM, Lazar AJ, Rubin BP. Chapter 10: Molecular Pathology of Sarcomas, Section III of Foundations. In: Diagnostic Pathology: Cell and Tissue Based Molecular Diagnostic Pathology. Churchill Livingston (Elsevier): Oxford, UK, 2009.
27. Lazar AJ and Murphy GF. Chapter 25: Skin. In: Robbins and Cotran’s Pathologic Basis of Disease. 8th. Saunders (Elsevier): Chicago, 2009.
28. Lazar AJ. Chapter 22: The Skin. In: Robbins Basic Pathology, 8th Edition. 8th. Saunders (Elsevier): Chicago, 2007.
29. Lazar AJ. Chapter 32: Tumors of the Sebaceous Glands. In: Pathology of the Skin with Clinical Correlations. 3rd. Mosby (Elsevier): St. Louis, 2005.
30. Lazar AJ, McKee PH, Haefner H, Granter SR. Chapter 2: Non-infectious inflammatory disorders of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. Saunders (Elsevier): Chicago, 2005.
31. Lazar AJ, Granter SR, McKee PH, Haefner HK. Chapter 4: Infectious disorders of the lower genital tract. In: Diagnostic Gynecologic and Obstetric Pathology. 1. Saunders (Elsevier): Chicago, 2005.
32. Lazar AJ, Granter SR, Haefner, HK. Chapter 5: Benign cysts, rests and adnexal tumors and Cysts of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. Saunders (Elsevier): Chicago, 2005.
33. Granter SR, Lazar AJ, Haefner HK, McKee PH. Chapter 8: Melanocytic tumors of the vulva. In: Diagnostic Gynecologic and Obstetric Pathology. Saunders (Elsevier): Chicago, 2005.
34. Lazar AJ, Granter SR. Chapter 13: Neoplastic and Non-neoplastic Vascular Tumors. In: Atlas of Heart Diseases, Vascular Diseases. 2nd. Mosby (Elsevier): St. Louis, 2003.

Books (edited and written)

1. WHO authors. Soft Tissue and Bone Tumours. In: WHO Classification of Tumours 5th Edition. Ed(s) WHO Classification of Tumours Editorial Board. 5th. IARC Press: Villeurbanne, France, 607, 2020.
2. WHO authors. Female Genital Tumours. In: WHO Classification of Tumors 5th Edition. Ed(s) WHO Classification of Tumours Editorial Board. 5th. IARC Press: Villeurbanne, France, 632, 2020.
3. Calonje E, Lazar AJ, Luzar B. Diagnostic Atlas of Cutaneous Mesenchymal Neoplasia. Ed(s) Calonje E, Lazar AJ, Luzar B. 1st. Elsevier, 640, 2019.
4. WHO authors. Digestive System Tumours. In: WHO Classification of Tumours 5th Edition. Ed(s) WHO Classification of Tumours Editorial Board. 5th. IARC Press: Villeurbanne, France, 635, 2019.
5. WHO authors. Breast Tumours. In: WHO Classification of Tumours 5th Edition. Ed(s) WHO Classification of Tumours Editorial Board. 5th. IARC Press: Villeurbanne, France, 356, 2019.
6. WHO authors. WHO Classification of Skin Tumors (Editor, Soft tissue and Genetic Syndromes chapters). In: WHO / IARC (Blue books). 4th. IARC Press: Geneva, Switzerland, 2018.
7. Multi-authored. McKee's Pathology of the Skin with Clinical Correlations, 5th ed. Ed(s) Calonje E, Brenn T, Lazar AJ, Billings SD. 5th. Elsevier: Edinburgh, Scotland, UK, 1803, 2018.
8. Multi-authored. Pathology of the Skin with Clinical Correlations 4th ed. Ed(s) Calonje E, Brenn T, Lazar AJ, McKee PH. 4th. Saunders/Elsevier, 1902, 2012.